Stay updated on Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updates to the study timeline include a primary completion date of 2026-06-30 and a study completion date of 2026-06-30, with additional updates logged on 2025-12-28 and 2025-12-30.
    Difference
    0.3%
    Check dated 2025-12-31T00:18:47.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Locations now include Missouri; the Missouri Locations entry was removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:15:45.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Updated the Publications section to state that PubMed publications are automatically filled in from PubMed, and updated the revision label from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:31:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page no longer displays the government funding lapse notice. This change does not affect any study details, eligibility criteria, or locations.
    Difference
    0.4%
    Check dated 2025-11-18T07:19:47.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Adds sponsor/collaborator institutions—Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine—and a new 'Helpful Links Provided by' section.
    Difference
    0.6%
    Check dated 2025-11-03T21:22:14.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The affiliations for Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, and for Washington University School of Medicine, have been removed. The 'Helpful Links Provided by' section is no longer displayed.
    Difference
    0.2%
    Check dated 2025-10-27T20:39:38.000Z thumbnail image

Stay in the know with updates to Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.